Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6164869

N#Cc1ccccc1-c1ccc(NC(=O)[C@@H]2C[C@@H]2c2cccc(N)c2C=NO)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR1 P21462 2/20 0.35
FPR2 P25090 2/20 0.35
ABL1 P00519 1/20 0.34
DEGS1 O15121 1/20 0.34
HDAC3 O15379 2/20 0.34
NCOR2 Q9Y618 2/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
F10 P00742 2/20 0.33
PTPN5 P54829 1/20 0.33
F2 P00734 1/20 0.33
PRSS1 P07477 1/20 0.33
NAMPT P43490 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP3A4 P08684 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6165932 0.90 ABL1 (0.33) ABL1DEGS1HDAC3NCOR2HDAC1
Trifluoroacetic Acid SCHEMBL6163894 0.88 S1PR1 (0.34) FPR1FPR2ABL1DEGS1HDAC3
Trifluoroacetic Acid SCHEMBL6163935 0.86 F10 (0.46) F10F2PRSS1
Trifluoroacetic Acid SCHEMBL6163846 0.84 FPR2 (0.41) FPR2F10F2PRSS1SCN3A
Trifluoroacetic Acid SCHEMBL6163938 0.81 F10 (0.39) HDAC3NCOR2HDAC1HDAC2F10
SCHEMBL6165688 0.79 F10 (0.43) FPR1FPR2F10F2PRSS1
Trifluoroacetic Acid SCHEMBL6164863 0.75 MEN1 (0.34) FPR1FPR2ABL1DEGS1HDAC3
SCHEMBL6166613 0.73 DEGS1 (0.43) DEGS1HDAC3NCOR2HDAC1HDAC2
Trifluoroacetic Acid SCHEMBL6163770 0.70 DEGS1 (0.37) ABL1DEGS1HDAC3NCOR2HDAC1
Trifluoroacetic Acid SCHEMBL6163890 0.70 S1PR1 (0.32) FPR1FPR2ABL1DEGS1F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof LG CHEM INVESTMENT LTD. (KR) 2003-04-03 US claimed
EP-1254136-A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF LG CHEM INVESTMENT LTD (KR) 2005-06-01 EP disclosed
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof LG CHEM INVESTMENT LTD. (KR) 2003-04-03 US disclosed
EP-1254136-A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF LG Chem Investment, Ltd. (KR) 2002-11-06 EP disclosed
WO-2001055146-A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF LG CHEM INVESTMENT LTD. (KR) 2001-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof F2, F12, TFPI FPR1 284/4885FPR2 607/4885ABL1 1437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.